Pain News and Research

Latest Pain News and Research

Researchers to study effectiveness of palliative care home health visits for people with HIV

Researchers to study effectiveness of palliative care home health visits for people with HIV

Comprehensive analysis of disease burden in US

Comprehensive analysis of disease burden in US

Auspex enrolls first patient in SD-809 Phase 3 trial for treatment of chorea associated with HD

Auspex enrolls first patient in SD-809 Phase 3 trial for treatment of chorea associated with HD

Dr. Reddy's Laboratories launches Decitabine for Injection

Dr. Reddy's Laboratories launches Decitabine for Injection

Researchers identify receptor mutation that blocked estrogen action in young woman

Researchers identify receptor mutation that blocked estrogen action in young woman

Phase III study: REVLIMID meets primary endpoint in patients newly diagnosed with multiple myeloma

Phase III study: REVLIMID meets primary endpoint in patients newly diagnosed with multiple myeloma

State highlights: Disabled at risk at Calif. facilities, audit finds; Advocates push for single policy for kids' medical, dental coverage in exchange plans; Ga. maternal mortality

State highlights: Disabled at risk at Calif. facilities, audit finds; Advocates push for single policy for kids' medical, dental coverage in exchange plans; Ga. maternal mortality

Bristol-Myers Squibb, Pfizer announce FDA acceptance of Eliquis sNDA for review

Bristol-Myers Squibb, Pfizer announce FDA acceptance of Eliquis sNDA for review

Research on activating Glial Cells to be presented at 7th Annual Pain Therapeutics Summit East

Research on activating Glial Cells to be presented at 7th Annual Pain Therapeutics Summit East

"Kangaroo care" delivers benefits beyond bonding and breastfeeding for tiniest newborns

"Kangaroo care" delivers benefits beyond bonding and breastfeeding for tiniest newborns

Study links vitamin D deficiency to accelerated aging of bones

Study links vitamin D deficiency to accelerated aging of bones

Robotic retroperitoneal lymph node dissection (RPLND) for testicular cancer: an interview with Dr. Stephen Williams of St. Joseph Hospital in Orange

Robotic retroperitoneal lymph node dissection (RPLND) for testicular cancer: an interview with Dr. Stephen Williams of St. Joseph Hospital in Orange

First Edition: July 10, 2013

First Edition: July 10, 2013

Pfizer's Prevenar 13 receives European approval to include adults for prevention of invasive disease

Pfizer's Prevenar 13 receives European approval to include adults for prevention of invasive disease

Acetaminophen overdose survivors have lower overall health following acute liver failure

Acetaminophen overdose survivors have lower overall health following acute liver failure

Orlando Health and UF health partner to expand neurosurgery program

Orlando Health and UF health partner to expand neurosurgery program

AMA establishes new CPT code for RF Ablation of Uterine Fibroids

AMA establishes new CPT code for RF Ablation of Uterine Fibroids

AOSSM presents awards and grants to encourage research in orthopaedic sports medicine

AOSSM presents awards and grants to encourage research in orthopaedic sports medicine

RUB chemists track interaction of enkephalin messengers with opioid receptor

RUB chemists track interaction of enkephalin messengers with opioid receptor

TGA of Australia approves Vertex Pharmaceuticals' KALYDECO for cystic fibrosis

TGA of Australia approves Vertex Pharmaceuticals' KALYDECO for cystic fibrosis

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.